An authorized generic is a brand-name drug sold under a generic label. No new FDA approval required. No new manufacturing […]

The gap between how small-molecule and biologic patents perform at the Patent Trial and Appeal Board has never been wider,

Pharmaceutical pay-for-delay agreements, the precise term is reverse payment patent settlements, sit at the intersection of Hatch-Waxman exclusivity mechanics, branded

Section 1: What an Authorized Generic Actually Is (And Why Definitions Matter for Deal Modeling) 1.1 The Core Definition An

For IP teams, portfolio managers, R&D leads, and institutional investors who need more than an overview. A pharmaceutical patent is

On NPR’s All Things Considered, Sydney Lupkin asked DrugPatentWatch if drug patents could be used to identify injector pens which

1. Why the 505(b)(2) Pathway Exists and Who It Rewards The Hatch-Waxman Design Intent The Drug Price Competition and Patent